Executive director of breast department of Guangdong Provincial People's Hospital, engaged in clinical work of breast cancer for more than 25 years, and chairman of China-US breast cancer summit forum. As the first researcher, he undertook many national natural science funds and national natural science youth funds, and published many works included in SCI in authoritative foreign magazines.
1997- 1999 won the French national scholarship and went to the French National Cancer Center to receive breast specialist training. He has mastered breast care, breast reconstruction technology and various breast operations for 20 years.
In 2006, Guangdong Provincial People's Hospital sent a delegation to the Medical College of Auxeden University in Denmark to study the drug treatment of advanced breast cancer. 20 14 The University of Texas MD Anderson Cancer Center, USA (ranked first in the United States for ten consecutive years) for further study. In June 2023, he participated in the program "AI Future Night".
Academic position:
Member of the International Council of the American Association of Oncology Surgeons; Member of the International Council of the International Sentinel Lymph Node Association; Member of the Expert Group of American NCCN Breast Cancer Guidelines (Chinese Version).
Member of the expert group of StGallen International Breast Cancer Guide (Chinese version); Member of the editorial board of the American Yearbook of Oncology, Yearbook of Surgical Oncology; Member of the compilation group of "Guidelines for the Treatment of Breast Cancer" of the Medical Administration Department of the National Health and Wellness Committee.
Member of the Expert Group of Diagnostic Guidelines for Breast Cancer of National Health and Wellness Committee; Member of the Expert Group of the Expert Committee on Rational Drug Use of "Tumor Drugs Group" of the National Health and Wellness Committee.
Reference to the above content: Baidu Encyclopedia-Liao Ning